Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Curdin Conrad

Showing results (71-80 of 117) with videos related to

Pageof 12
Sort By:
The Journal of Investigative Dermatology|February 10, 2019
IL-17E (IL-25) Enhances Innate Immune Responses during Skin InflammationLuisa Senra, Alessio Mylonas, Ruairi D Kavanagh, et al.
International Journal of Molecular Sciences|February 10, 2021
Complementary Effects of Carbamylated and Citrullinated LL37 in Autoimmunity and Inflammation in Systemic Lupus ErythematosusRoberto Lande, Immacolata Pietraforte, Anna Mennella, et al.
Nature Immunology|July 15, 2020
The commensal skin microbiota triggers type I IFN-dependent innate repair responses in injured skinJeremy Di Domizio, Cyrine Belkhodja, Pauline Chenuet, et al.
Dermatology and Therapy|August 17, 2024
Progression of Quality of Life in Patients with Plaque Psoriasis Who Achieved Three or More Years of Complete Skin Clearance with Guselkumab Treatment: a Post hoc Analysis of the VOYAGE 1 Clinical TrialLuis Puig, Antonio Costanzo, Elke M G J de Jong, et al.
American Journal of Clinical Dermatology|October 7, 2023
Guselkumab-Treated Patients with Plaque Psoriasis Who Achieved Complete Skin Clearance for ≥ 156 Consecutive Weeks: A Post-Hoc Analysis From the VOYAGE 1 Clinical TrialLuis Puig, Antonio Costanzo, Elke M G J de Jong, et al.
Dermatology and Therapy|November 23, 2021
Real-World Experience of Patient-Relevant Benefits and Treatment Satisfaction with Apremilast in Patients with Psoriasis: An Analysis of the APPRECIATE StudyToni Maria Klein, Christine Blome, C Elise Kleyn, et al.
International Journal of Dermatology|August 7, 2024
Predictors of initiating biologics in the treatment of psoriasisEmilia Linnemann, Mia-Louise Nielsen, Lara Valeska Maul, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 9, 2023
Freedom from disease in plaque psoriasis: Comparing the perceived importance of voting round 2 statements from a Delphi consensus of patients, physicians and nursesIlse van Ee, Elfie Deprez, Alexander Egeberg, et al.
Dermatology (Basel, Switzerland)|June 21, 2016
Swiss S1 Guidelines on the Systemic Treatment of Psoriasis VulgarisAntonios G A Kolios, Nikhil Yawalkar, Mark Anliker, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 20, 2010
Cutting edge: A critical functional role for IL-23 in psoriasisGiulia Tonel, Curdin Conrad, Ute Laggner, et al.
Pageof 12

Showing results (71-80 of 117) with videos related to

Sort By:
Pageof 12
The Journal of Investigative Dermatology|February 10, 2019
IL-17E (IL-25) Enhances Innate Immune Responses during Skin InflammationLuisa Senra, Alessio Mylonas, Ruairi D Kavanagh, et al.
International Journal of Molecular Sciences|February 10, 2021
Complementary Effects of Carbamylated and Citrullinated LL37 in Autoimmunity and Inflammation in Systemic Lupus ErythematosusRoberto Lande, Immacolata Pietraforte, Anna Mennella, et al.
Nature Immunology|July 15, 2020
The commensal skin microbiota triggers type I IFN-dependent innate repair responses in injured skinJeremy Di Domizio, Cyrine Belkhodja, Pauline Chenuet, et al.
Dermatology and Therapy|August 17, 2024
Progression of Quality of Life in Patients with Plaque Psoriasis Who Achieved Three or More Years of Complete Skin Clearance with Guselkumab Treatment: a Post hoc Analysis of the VOYAGE 1 Clinical TrialLuis Puig, Antonio Costanzo, Elke M G J de Jong, et al.
American Journal of Clinical Dermatology|October 7, 2023
Guselkumab-Treated Patients with Plaque Psoriasis Who Achieved Complete Skin Clearance for ≥ 156 Consecutive Weeks: A Post-Hoc Analysis From the VOYAGE 1 Clinical TrialLuis Puig, Antonio Costanzo, Elke M G J de Jong, et al.
Dermatology and Therapy|November 23, 2021
Real-World Experience of Patient-Relevant Benefits and Treatment Satisfaction with Apremilast in Patients with Psoriasis: An Analysis of the APPRECIATE StudyToni Maria Klein, Christine Blome, C Elise Kleyn, et al.
International Journal of Dermatology|August 7, 2024
Predictors of initiating biologics in the treatment of psoriasisEmilia Linnemann, Mia-Louise Nielsen, Lara Valeska Maul, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 9, 2023
Freedom from disease in plaque psoriasis: Comparing the perceived importance of voting round 2 statements from a Delphi consensus of patients, physicians and nursesIlse van Ee, Elfie Deprez, Alexander Egeberg, et al.
Dermatology (Basel, Switzerland)|June 21, 2016
Swiss S1 Guidelines on the Systemic Treatment of Psoriasis VulgarisAntonios G A Kolios, Nikhil Yawalkar, Mark Anliker, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 20, 2010
Cutting edge: A critical functional role for IL-23 in psoriasisGiulia Tonel, Curdin Conrad, Ute Laggner, et al.
Pageof 12